{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "29789647", "DateCompleted": {"Year": "2019", "Month": "11", "Day": "05"}, "DateRevised": {"Year": "2019", "Month": "11", "Day": "05"}, "Article": {"ArticleDate": [{"Year": "2018", "Month": "05", "Day": "22"}], "Language": ["eng"], "ELocationID": ["7980", "10.1038/s41598-018-26306-7"], "Journal": {"ISSN": "2045-2322", "JournalIssue": {"Volume": "8", "Issue": "1", "PubDate": {"Year": "2018", "Month": "May", "Day": "22"}}, "Title": "Scientific reports", "ISOAbbreviation": "Sci Rep"}, "ArticleTitle": "Microbial production of novel sulphated alkaloids for drug discovery.", "Pagination": {"StartPage": "7980", "MedlinePgn": "7980"}, "Abstract": {"AbstractText": ["Natural products from plants are useful as lead compounds in drug discovery. Plant benzylisoquinoline alkaloids (BIAs) exhibit various pharmaceutical activities. Although unidentified BIAs are expected to be of medicinal value, sufficient quantities of such BIAs, for biological assays, are sometimes difficult to obtain due to their low content in natural sources. Here, we showed that high productivity of BIAs in engineered Escherichia coli could be exploited for drug discovery. First, we improved upon the previous microbial production system producing (S)-reticuline, an important BIA intermediate, to obtain yields of around 160\u2009mg/L, which was 4-fold higher than those of the previously reported highest production system. Subsequently, we synthesised non-natural BIAs (O-sulphated (S)-reticulines) by introducing human sulphotransferases into the improved (S)-reticuline production system. Analysis of human primary cells treated with these BIAs demonstrated that they affected a biomarker expression in a manner different from that by the parent compound (S)-reticuline, suggesting that simple side-chain modification altered the characteristic traits of BIA. These results indicated that highly productive microbial systems might facilitate the production of scarce or novel BIAs and enable subsequent evaluation of their biological activities. The system developed here could be applied to other rare natural products and might contribute to the drug-discovery process as a next-generation strategy."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Research Institute for Bioresources and Biotechnology, Ishikawa Prefectural University, 1-308 Suematsu, Nonoichi, Ishikawa, 921-8836, Japan."}], "LastName": "Matsumura", "ForeName": "Eitaro", "Initials": "E"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Research Institute for Bioresources and Biotechnology, Ishikawa Prefectural University, 1-308 Suematsu, Nonoichi, Ishikawa, 921-8836, Japan."}], "LastName": "Nakagawa", "ForeName": "Akira", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Applied Chemistry, School of Engineering, Tokai University, 4-1-1 Kitakaname, Hiratsuka, Kanagawa, 259-1292, Japan."}], "LastName": "Tomabechi", "ForeName": "Yusuke", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biotechnology, Faculty of Engineering, Toyama Prefectural University, 5180 Kurokawa, Imizu, Toyama, 939-0398, Japan."}], "LastName": "Ikushiro", "ForeName": "Shinichi", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biotechnology, Faculty of Engineering, Toyama Prefectural University, 5180 Kurokawa, Imizu, Toyama, 939-0398, Japan."}], "LastName": "Sakaki", "ForeName": "Toshiyuki", "Initials": "T"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Division of Integrated Life Science, Graduate School of Biostudies, Kyoto University, Sakyo-ku, Kyoto, 606-8502, Japan."}], "LastName": "Katayama", "ForeName": "Takane", "Initials": "T"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Research Institute for Bioresources and Biotechnology, Ishikawa Prefectural University, 1-308 Suematsu, Nonoichi, Ishikawa, 921-8836, Japan."}], "LastName": "Yamamoto", "ForeName": "Kenji", "Initials": "K"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Research Institute for Bioresources and Biotechnology, Ishikawa Prefectural University, 1-308 Suematsu, Nonoichi, Ishikawa, 921-8836, Japan."}], "LastName": "Kumagai", "ForeName": "Hidehiko", "Initials": "H"}, {"Identifier": ["0000-0001-9497-4452"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Division of Integrated Life Science, Graduate School of Biostudies, Kyoto University, Sakyo-ku, Kyoto, 606-8502, Japan."}], "LastName": "Sato", "ForeName": "Fumihiko", "Initials": "F"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Research Institute for Bioresources and Biotechnology, Ishikawa Prefectural University, 1-308 Suematsu, Nonoichi, Ishikawa, 921-8836, Japan. minami@ishikawa-pu.ac.jp."}], "LastName": "Minami", "ForeName": "Hiromichi", "Initials": "H"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "Sci Rep", "NlmUniqueID": "101563288", "ISSNLinking": "2045-2322"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Alkaloids"}, {"RegistryNumber": "0", "NameOfSubstance": "Benzylisoquinolines"}, {"RegistryNumber": "0", "NameOfSubstance": "Sulfates"}, {"RegistryNumber": "EC 1.14.16.2", "NameOfSubstance": "Tyrosine 3-Monooxygenase"}, {"RegistryNumber": "X35Z551WT4", "NameOfSubstance": "reticuline"}], "MeshHeadingList": [{"QualifierName": ["biosynthesis", "metabolism"], "DescriptorName": "Alkaloids"}, {"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["metabolism"], "DescriptorName": "Benzylisoquinolines"}, {"QualifierName": ["enzymology", "genetics"], "DescriptorName": "Drosophila melanogaster"}, {"QualifierName": [], "DescriptorName": "Drug Discovery"}, {"QualifierName": ["genetics", "metabolism"], "DescriptorName": "Escherichia coli"}, {"QualifierName": ["methods"], "DescriptorName": "Metabolic Engineering"}, {"QualifierName": [], "DescriptorName": "Organisms, Genetically Modified"}, {"QualifierName": ["metabolism"], "DescriptorName": "Sulfates"}, {"QualifierName": ["genetics", "metabolism"], "DescriptorName": "Tyrosine 3-Monooxygenase"}], "CoiStatement": "The authors declare no competing interests."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Newman DJ, Cragg GM. Natural products as sources of new drugs over the 30 years from 1981 to 2010. J. Nat. Prod. 2012;75:311\u2013335. doi: 10.1021/np200906s.", "ArticleIdList": ["10.1021/np200906s", "PMC3721181", "22316239"]}, {"Citation": "Song MC, et al. Microbial biosynthesis of medicinally important plant secondary metabolites. Nat. Prod. Rep. 2014;31:1497\u20131509. doi: 10.1039/C4NP00057A.", "ArticleIdList": ["10.1039/C4NP00057A", "25072622"]}, {"Citation": "Peplow M. Synthetic biology\u2019s first malaria drug meets market resistance. Nature. 2016;530:389\u2013390. doi: 10.1038/530390a.", "ArticleIdList": ["10.1038/530390a", "26911755"]}, {"Citation": "Qian P, Yang X-W. Five new alkaloids from Coptidis Rhizoma\u2013Euodiae Fructus couple and their cytotoxic activities against gastrointestinal cancer cells. Fitoterapia. 2014;93:74\u201380. doi: 10.1016/j.fitote.2013.12.016.", "ArticleIdList": ["10.1016/j.fitote.2013.12.016", "24384278"]}, {"Citation": "Lv J-J, et al. Cytotoxic bisbenzylisoquinoline alkaloids from Stephania epigaea. J. Nat. Prod. 2013;76:926\u2013932. doi: 10.1021/np400084t.", "ArticleIdList": ["10.1021/np400084t", "23621840"]}, {"Citation": "Ziegler J, Facchini PJ. Alkaloid biosynthesis: metabolism and trafficking. Annu. Rev. Plant Biol. 2008;59:735\u2013769. doi: 10.1146/annurev.arplant.59.032607.092730.", "ArticleIdList": ["10.1146/annurev.arplant.59.032607.092730", "18251710"]}, {"Citation": "Nakagawa A, et al. A bacterial platform for fermentative production of plant alkaloids. Nat. Commun. 2011;2:326. doi: 10.1038/ncomms1327.", "ArticleIdList": ["10.1038/ncomms1327", "PMC3112539", "21610729"]}, {"Citation": "DeLoache WC, et al. An enzyme-coupled biosensor enables (S)-reticuline production in yeast from glucose. Nat. Chem. Biol. 2015;11:465\u2013471. doi: 10.1038/nchembio.1816.", "ArticleIdList": ["10.1038/nchembio.1816", "25984720"]}, {"Citation": "Trenchard IJ, Siddiqui MS, Thodey K, Smolke CD. De novo production of the key branch point benzylisoquinoline alkaloid reticuline in yeast. Metab. Eng. 2015;31:74\u201383. doi: 10.1016/j.ymben.2015.06.010.", "ArticleIdList": ["10.1016/j.ymben.2015.06.010", "PMC4575844", "26166409"]}, {"Citation": "Nakagawa A, et al. Total biosynthesis of opiates by stepwise fermentation using engineered Escherichia coli. Nat. Commun. 2016;7:10390. doi: 10.1038/ncomms10390.", "ArticleIdList": ["10.1038/ncomms10390", "PMC4748248", "26847395"]}, {"Citation": "Galanie S, Thodey K, Trenchard IJ, Filsinger Interrante M, Smolke CD. Complete biosynthesis of opioids in yeast. Science. 2015;349:1095\u20131100. doi: 10.1126/science.aac9373.", "ArticleIdList": ["10.1126/science.aac9373", "PMC4924617", "26272907"]}, {"Citation": "Berg EL, et al. Chemical target and pathway toxicity mechanisms defined in primary human cell systems. J. Pharmacol. Toxicol. Methods. 2010;61:3\u201315. doi: 10.1016/j.vascn.2009.10.001.", "ArticleIdList": ["10.1016/j.vascn.2009.10.001", "19879948"]}, {"Citation": "Berg EL, Hsu Y-C, Lee JA. Consideration of the cellular microenvironment: physiologically relevant co-culture systems in drug discovery. Adv. Drug Deliv. Rev. 2014;69\u201370:190\u2013204. doi: 10.1016/j.addr.2014.01.013.", "ArticleIdList": ["10.1016/j.addr.2014.01.013", "24524933"]}, {"Citation": "Hern\u00e1ndez-Romero D, Sanchez-Amat A, Solano F. A tyrosinase with an abnormally high tyrosine hydroxylase/dopa oxidase ratio. FEBS J. 2006;273:257\u2013270. doi: 10.1111/j.1742-4658.2005.05038.x.", "ArticleIdList": ["10.1111/j.1742-4658.2005.05038.x", "16403014"]}, {"Citation": "Pribat A, et al. FolX and FolM are essential for tetrahydromonapterin synthesis in Escherichia coli and Pseudomonas aeruginosa. J. Bacteriol. 2010;192:475\u2013482. doi: 10.1128/JB.01198-09.", "ArticleIdList": ["10.1128/JB.01198-09", "PMC2805310", "19897652"]}, {"Citation": "Yamamoto K, et al. Genetic engineering of Escherichia coli for production of tetrahydrobiopterin. Metab. Eng. 2003;5:246\u2013254. doi: 10.1016/S1096-7176(03)00046-6.", "ArticleIdList": ["10.1016/S1096-7176(03)00046-6", "14642352"]}, {"Citation": "Wang L-Q, James MO. Inhibition of sulfotransferases by xenobiotics. Curr. Drug Metab. 2006;7:83\u2013104. doi: 10.2174/138920006774832596.", "ArticleIdList": ["10.2174/138920006774832596", "16454694"]}, {"Citation": "Berg EL, Yang J, Polokoff MA. Building predictive models for mechanism-of-action classification from phenotypic assay data sets. J. Biomol. Screen. 2013;18:1260\u20131269. doi: 10.1177/1087057113505324.", "ArticleIdList": ["10.1177/1087057113505324", "24088371"]}, {"Citation": "Martin ML, et al. Antispasmodic activity of benzylisoquinoline alkaloids analogous to papaverine. Planta Med. 1993;59:63\u201367. doi: 10.1055/s-2006-959606.", "ArticleIdList": ["10.1055/s-2006-959606", "8441784"]}, {"Citation": "Akiyama H, et al. Expression of intercellular adhesion molecule (ICAM)\u22121 by a subset of astrocytes in Alzheimer disease and some other degenerative neurological disorders. Acta Neuropathol. 1993;85:628\u2013634. doi: 10.1007/BF00334673.", "ArticleIdList": ["10.1007/BF00334673", "8337942"]}, {"Citation": "Hu J, V den Steen PE, Sang Q-XA, Opdenakker G. Matrix metalloproteinase inhibitors as therapy for inflammatory and vascular diseases. Nat. Rev. Drug Discov. 2007;6:480\u2013498. doi: 10.1038/nrd2308.", "ArticleIdList": ["10.1038/nrd2308", "17541420"]}, {"Citation": "Rubio-Perez JM, Morillas-Ruiz JM. A review: inflammatory process in Alzheimer\u2019s disease, role of cytokines. Sci. World J. 2012;2012:756357. doi: 10.1100/2012/756357.", "ArticleIdList": ["10.1100/2012/756357", "PMC3330269", "22566778"]}, {"Citation": "Satoh Y, Tajima K, Munekata M, Keasling JD, Lee TS. Engineering of l-tyrosine oxidation in Escherichia coli and microbial production of hydroxytyrosol. Metab. Eng. 2012;14:603\u2013610. doi: 10.1016/j.ymben.2012.08.002.", "ArticleIdList": ["10.1016/j.ymben.2012.08.002", "22948011"]}, {"Citation": "Sakakibara Y, et al. Manganese-dependent Dopa/tyrosine sulfation in HepG2 human hepatoma cells: novel Dopa/tyrosine sulfotransferase activities associated with the human monoamine-form phenol sulfotransferase. Biochim. Biophys. Acta. 2003;1355:102\u2013106. doi: 10.1016/S0167-4889(96)00166-8.", "ArticleIdList": ["10.1016/S0167-4889(96)00166-8", "9042329"]}, {"Citation": "Dajani R, Hood AM, Coughtrie MWH. A single amino acid, Glu146, governs the substrate specificity of a human dopamine sulfotransferase, SULT1A3. Mol. Pharmacol. 1998;54:942\u2013948. doi: 10.1124/mol.54.6.942.", "ArticleIdList": ["10.1124/mol.54.6.942", "9855620"]}, {"Citation": "Cook I, Wang T, Leyh TS. Tetrahydrobiopterin regulates monoamine neurotransmitter sulfonation. Proc. Natl. Acad. Sci. USA. 2017;114:E5317\u2013E5324. doi: 10.1073/pnas.1704500114.", "ArticleIdList": ["10.1073/pnas.1704500114", "PMC5502633", "28630292"]}, {"Citation": "Fossati E, et al. Reconstitution of a 10-gene pathway for synthesis of the plant alkaloid dihydrosanguinarine in Saccharomyces cerevisiae. Nat. Commun. 2014;5:3283. doi: 10.1038/ncomms4283.", "ArticleIdList": ["10.1038/ncomms4283", "24513861"]}, {"Citation": "Hori K, Okano S, Sato F. Efficient microbial production of stylopine using a Pichia pastoris expression system. Sci. Rep. 2016;6:22201. doi: 10.1038/srep22201.", "ArticleIdList": ["10.1038/srep22201", "PMC4770593", "26923560"]}, {"Citation": "Trenchard IJ, Smolke CD. Engineering strategies for the fermentative production of plant alkaloids in yeast. Metab. Eng. 2015;30:96\u2013104. doi: 10.1016/j.ymben.2015.05.001.", "ArticleIdList": ["10.1016/j.ymben.2015.05.001", "PMC4519383", "25981946"]}, {"Citation": "Kim J-S, et al. Improvement of reticuline productivity from dopamine by using engineered Escherichia coli. Biosci. Biotechnol. Biochem. 2013;77:2166\u20132168. doi: 10.1271/bbb.130552.", "ArticleIdList": ["10.1271/bbb.130552", "24096658"]}, {"Citation": "Haselmayer P, et al. Characterization of novel PI3K\u03b4 inhibitors as potential therapeutics for SLE and lupus nephritis in pre-clinical studies. Front. Immunol. 2014;5:233. doi: 10.3389/fimmu.2014.00233.", "ArticleIdList": ["10.3389/fimmu.2014.00233", "PMC4033217", "24904582"]}]}], "History": [{"Year": "2018", "Month": "2", "Day": "26"}, {"Year": "2018", "Month": "5", "Day": "4"}, {"Year": "2018", "Month": "5", "Day": "24", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "5", "Day": "24", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "11", "Day": "7", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "5", "Day": "22"}], "PublicationStatus": "epublish", "ArticleIdList": ["29789647", "PMC5964154", "10.1038/s41598-018-26306-7", "10.1038/s41598-018-26306-7"]}}]}